177 related articles for article (PubMed ID: 30325317)
1. Infantile bullous pemphigoid following vaccination.
Guerra L; Pedicelli C; Fania L; De Luca N; Condorelli AG; Mazzanti C; Di Zenzo G
Eur J Dermatol; 2018 Oct; 28(5):708-710. PubMed ID: 30325317
[No Abstract] [Full Text] [Related]
2. [Infantile bullous pemphigoid developing after hexavalent, meningococcal and pneumococcal vaccinations].
Valdivielso-Ramos M; Velázquez D; Tortoledo A; Hernanz JM
An Pediatr (Barc); 2011 Sep; 75(3):199-202. PubMed ID: 21676664
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine.
Halperin SA; Tapiéro B; Dionne M; Meekison W; Diaz-Mitoma F; Zickler P; Rubin E; Embree J; Bhuyan P; Lee A; Li M; Tomovici A
Pediatr Infect Dis J; 2014 Jan; 33(1):73-80. PubMed ID: 24346596
[TBL] [Abstract][Full Text] [Related]
4. [Bullous pemphigoid in an infant after vaccination].
Mérida C; Martínez-Escribano JA; Frías JF; Sánchez-Pedreño P; Corbalán R
Actas Dermosifiliogr; 2005 May; 96(4):255-7. PubMed ID: 16476379
[TBL] [Abstract][Full Text] [Related]
5. Sensorimotor polyneuropathy after hexavalent vaccination.
Gorczyca D; Schwirten U
Scand J Infect Dis; 2014 Jan; 46(1):66-8. PubMed ID: 24053264
[TBL] [Abstract][Full Text] [Related]
6. Effect of routine vaccination on aluminum and essential element levels in preterm infants.
Movsas TZ; Paneth N; Rumbeiha W; Zyskowski J; Gewolb IH
JAMA Pediatr; 2013 Sep; 167(9):870-2. PubMed ID: 23856981
[No Abstract] [Full Text] [Related]
7. Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with DTPw-HBV/Hib and poliovirus vaccines.
Bermal N; Szenborn L; Edison A; Hernandez M; Pejcz J; Majda-Stanislawska E; Gatchalian S; Fanic A; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2011 Jan; 30(1):69-72. PubMed ID: 20980933
[TBL] [Abstract][Full Text] [Related]
8. Differences by sex in IgG levels following infant and childhood vaccinations: An individual participant data meta-analysis of vaccination studies.
Boef AGC; van der Klis FRM; Berbers GAM; Buisman AM; Sanders EAM; Kemmeren JM; van der Ende A; de Melker HE; Rots NY; Knol MJ
Vaccine; 2018 Jan; 36(3):400-407. PubMed ID: 29223483
[TBL] [Abstract][Full Text] [Related]
9. Postvaccination bullous pemphigoid in infancy: report of three new cases and literature review.
de la Fuente S; Hernández-Martín Á; de Lucas R; González-Enseñat MA; Vicente A; Colmenero I; González-Beato M; Suñol M; Torrelo A
Pediatr Dermatol; 2013; 30(6):741-4. PubMed ID: 24125034
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine.
Cheng HK; Rajadurai VS; Amin Z; Sriram B; Yee MF; Han HH; Bock HL; Safary A
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):685-92. PubMed ID: 15689088
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).
Martinón-Torres F; Boisnard F; Thomas S; Sadorge C; Borrow R;
Vaccine; 2017 Jun; 35(30):3764-3772. PubMed ID: 28583305
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine.
Gimenez-Sanchez F; Kieninger DM; Kueper K; Martinon-Torres F; Bernaola E; Diez-Domingo J; Steul K; Juergens C; Gurtman A; Giardina P; Liang JZ; Gruber WC; Emini EA; Scott DA;
Vaccine; 2011 Aug; 29(35):6042-8. PubMed ID: 21704105
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of a hexavalent vaccine administered at 2, 4 and 6 months of age with or without a heptavalent pneumococcal conjugate vaccine: a randomized, open-label study.
Tapiéro B; Halperin SA; Dionne M; Meekison W; Diaz-Mitoma F; Zickler P; Rubin E; Embree J; Bhuyan P; Lee AW; Li M; Tomovici A
Pediatr Infect Dis J; 2013 Jan; 32(1):54-61. PubMed ID: 23241989
[TBL] [Abstract][Full Text] [Related]
14. 13-valent pneumococcal conjugate vaccine given with meningococcal C-tetanus toxoid conjugate and other routine pediatric vaccinations: immunogenicity and safety.
Martinón-Torres F; Gimenez-Sanchez F; Gurtman A; Bernaola E; Diez-Domingo J; Carmona A; Sidhu M; Sarkozy DA; Gruber WC; Emini EA; Scott DA;
Pediatr Infect Dis J; 2012 Apr; 31(4):392-9. PubMed ID: 22301472
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa.
Vesikari T; Rivera L; Korhonen T; Ahonen A; Cheuvart B; Hezareh M; Janssens W; Mesaros N
Hum Vaccin Immunother; 2017 Jul; 13(7):1505-1515. PubMed ID: 28340322
[TBL] [Abstract][Full Text] [Related]
16. A randomized, controlled trial to assess the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, hib and meningococcal serogroup C combination vaccine administered at 2, 3, 4 and 12-18 months of age.
Szenborn L; Czajka H; Brzostek J; Konior R; Caubet M; Ulianov L; Leyssen M
Pediatr Infect Dis J; 2013 Jul; 32(7):777-85. PubMed ID: 23838777
[TBL] [Abstract][Full Text] [Related]
17. Adverse reaction with hexavalent vaccine: An unusual case.
Tomás-Pérez M; Gómez-Traseira C; González-Muñoz M; Quirce S
Allergol Immunopathol (Madr); 2020; 48(6):801-803. PubMed ID: 32402623
[No Abstract] [Full Text] [Related]
18. Atypical aluminium patch tests in children with persistent itching postvaccinal nodules.
Raison-Peyron N; Genillier-Foin N; Bessis D; Milpied B
Pediatr Dermatol; 2018 Jul; 35(4):531-532. PubMed ID: 29656425
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and reactogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus and Haemophilus influenzae type B.
Shao PL; Lu CY; Hsieh YC; ; Bock HL; Huang LM
J Formos Med Assoc; 2011 May; 110(5):336-41. PubMed ID: 21621155
[TBL] [Abstract][Full Text] [Related]
20. Cold Contact Urticaria Following Vaccination: Four Cases.
Raison-Peyron N; Philibert C; Bernard N; Du-Thanh A; Barbaud A; Bessis D
Acta Derm Venereol; 2016 Aug; 96(6):852-3. PubMed ID: 26832889
[No Abstract] [Full Text] [Related]
[Next] [New Search]
